MX9300779A - 3- (1H-TETRAZOLE-5-Y1) -4H-PYRIDO [1,2-A] PIRIMIDINA-4-ONAS PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR PREPARATION THEREOF - Google Patents
3- (1H-TETRAZOLE-5-Y1) -4H-PYRIDO [1,2-A] PIRIMIDINA-4-ONAS PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR PREPARATION THEREOFInfo
- Publication number
- MX9300779A MX9300779A MX9300779A MX9300779A MX9300779A MX 9300779 A MX9300779 A MX 9300779A MX 9300779 A MX9300779 A MX 9300779A MX 9300779 A MX9300779 A MX 9300779A MX 9300779 A MX9300779 A MX 9300779A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrido
- preparation
- pirimidina
- onas
- tetrazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se relaciona con 3-(1H-tetrazol-5-il)-4H-pirido[1,2-a]pirimidin-4-o nas parcialmente nuevas de la fórmula general (I) y sales/o hidratos farmacéuticamente aceptables y con la preparación de las mismas. Estos compuestos poseen actividad antialérgica o antiulcerante significativa.The invention relates to partially new 3- (1H-tetrazol-5-yl) -4H-pyrido [1,2-a] pyrimidin-4-o nas of the general formula (I) and pharmaceutically acceptable salts / hydrates and with the preparation of the same. These compounds possess significant antiallergic or anti-ulcer activity.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9200432A HUT64064A (en) | 1992-02-13 | 1992-02-13 | Process for producing puyrido/1,2-a/pyrimidine derivatives and pharmaceutical compositions comprising same as active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9300779A true MX9300779A (en) | 1993-09-30 |
Family
ID=10981335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9300779A MX9300779A (en) | 1992-02-13 | 1993-02-12 | 3- (1H-TETRAZOLE-5-Y1) -4H-PYRIDO [1,2-A] PIRIMIDINA-4-ONAS PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR PREPARATION THEREOF |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN1080289A (en) |
| AU (1) | AU3573793A (en) |
| HU (1) | HUT64064A (en) |
| IL (1) | IL104706A0 (en) |
| MX (1) | MX9300779A (en) |
| SI (1) | SI9300075A (en) |
| WO (1) | WO1993016076A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU209793B (en) * | 1990-09-25 | 1994-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same |
| ITMI20011764A1 (en) * | 2001-08-10 | 2003-02-10 | Dinamite Dipharma Spa | HIGH PURITY PEMIROLAST METHOD |
| JP4690043B2 (en) * | 2002-10-04 | 2011-06-01 | プラナ バイオテクノロジー リミティッド | Nerve active compounds |
| WO2007093184A2 (en) * | 2006-02-13 | 2007-08-23 | Astion Pharma A/S | Treatment of mmp-mediated dermatological diseases with pemirolast |
| EP1818058A3 (en) * | 2006-02-13 | 2007-11-07 | Astion Pharma A/S | Treatment of mmp-mediated dermatological diseases with pemirolast |
| CN104945420A (en) | 2009-06-29 | 2015-09-30 | 因塞特公司 | Pyrimidinones as PI3K inhibitors |
| US8759359B2 (en) | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
| JP5816678B2 (en) | 2010-04-14 | 2015-11-18 | インサイト・コーポレイションIncyte Corporation | Condensed derivatives as PI3Kδ inhibitors |
| US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
| CA2822070C (en) | 2010-12-20 | 2019-09-17 | Incyte Corporation | N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| WO2012135009A1 (en) | 2011-03-25 | 2012-10-04 | Incyte Corporation | Pyrimidine-4,6-diamine derivatives as pi3k inhibitors |
| ES2873001T3 (en) | 2011-09-02 | 2021-11-03 | Incyte Holdings Corp | Heterocyclamines as PI3K inhibitors |
| AR090548A1 (en) | 2012-04-02 | 2014-11-19 | Incyte Corp | BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS |
| WO2015191677A1 (en) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors |
| JP6816005B2 (en) | 2015-02-27 | 2021-01-20 | インサイト・コーポレイションIncyte Corporation | Salts of PI3K inhibitors and processes for their preparation |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| MA52761A (en) | 2018-06-01 | 2021-04-14 | Incyte Corp | DOSAGE REGIMEN FOR THE TREATMENT OF PI3K-RELATED DISORDERS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2044796C (en) * | 1990-06-21 | 2001-10-16 | Atsunori Sano | Process for producing pyrido[1,2-a] pyrimidine derivative |
-
1992
- 1992-02-13 HU HU9200432A patent/HUT64064A/en unknown
-
1993
- 1993-02-12 AU AU35737/93A patent/AU3573793A/en not_active Withdrawn
- 1993-02-12 MX MX9300779A patent/MX9300779A/en unknown
- 1993-02-12 SI SI19939300075A patent/SI9300075A/en unknown
- 1993-02-12 IL IL104706A patent/IL104706A0/en unknown
- 1993-02-12 WO PCT/HU1993/000009 patent/WO1993016076A1/en not_active Ceased
- 1993-02-13 CN CN93102959.7A patent/CN1080289A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HU9200432D0 (en) | 1992-04-28 |
| AU3573793A (en) | 1993-09-03 |
| HUT64064A (en) | 1993-11-29 |
| WO1993016076A1 (en) | 1993-08-19 |
| SI9300075A (en) | 1993-09-30 |
| CN1080289A (en) | 1994-01-05 |
| IL104706A0 (en) | 1993-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9300779A (en) | 3- (1H-TETRAZOLE-5-Y1) -4H-PYRIDO [1,2-A] PIRIMIDINA-4-ONAS PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR PREPARATION THEREOF | |
| NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
| DE69231522D1 (en) | 1-SUBSTITUTED-4-AMINO-1H-IMIDAZO 4,5-C CHINOLINE, INTERMEDIATE PRODUCTS AND MEDICINAL PRODUCTS | |
| EE03177B1 (en) | Heterobicyclic compounds, methods for their preparation and pharmaceutical compositions containing said compounds | |
| NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
| FI970825A7 (en) | Pharmaceutical compositions containing bile salts and buffers to increase the bioavailability of the active compound | |
| SE8700499D0 (en) | NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS | |
| DE59009351D1 (en) | NEW ARYLPYRIDAZINE, THEIR PRODUCTION, USE AND MEDICINAL PRODUCTS CONTAINING IT. | |
| AU6542986A (en) | Pyridyl-methylthio substituted benzimidazoles | |
| SE9504661D0 (en) | New compounds | |
| ES2061252T3 (en) | ANTITUSIVE AGENT AND REGULATOR OF THE MUCOSA, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT. | |
| MX9300603A (en) | THIACICLIC DERIVATIVES OF PIPERIDINYL. | |
| KR890700125A (en) | New benzimidazole derivatives, preparation method thereof and pharmaceutical composition containing the compound | |
| PT1023267E (en) | PYRIDYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| NO953367L (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as drugs | |
| IL74745A0 (en) | Substituted benzopyrans,their preparation and pharmaceutical compositions containing them | |
| RU94038042A (en) | Derivatives of hexahydroazepine, pharmaceutical composition based on thereof and antipsychotropic agent | |
| ITRM910430A1 (en) | PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN WITH IMPROVED ABSORPTION, THEIR PREPARATION AND THEIR USE | |
| FR2686513B1 (en) | AQUEOUS PHARMACEUTICAL COMPOSITIONS OF SODIUM CROMOGLYCATE. | |
| NO983444L (en) | Benzo (c) quinolizine derivatives, their preparation and use as 5 <alfa> reductase inhibitors | |
| IT8822493A0 (en) | NEW ALKOXY DERIVATIVES OF GINKGOLIDS, THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM | |
| UA41350C2 (en) | MORPHOLINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND PHARMACEUTICAL COMPOSITION BASED ON IT | |
| ATE48993T1 (en) | AETHEROXIDE DERIVATIVES OF CYCLOPROPYLPHENOLS. | |
| SE9504662D0 (en) | New compounds | |
| SE9403137D0 (en) | Derivatives of carbohydrates and compositions containing them |